A few days ago, observers found it difficult to forecast the fate of the Lada XRAY as this topic had not yet reached the board for discussion. The situation is clear in the near term: the model is not in production due to an acute shortage of components, many of which were supplied by Renault. The pressing question remains: when will production of the Lada XRAY resume? The leadership at AvtoVAZ weighed in decisively to end the speculation.
According to a recent statement, the concise answer is that resuming production is not planned. The reasons are simple and stubborn: a large share of the auto parts used in this car is currently blocked for deliveries. This assessment was reported by TASS, quoting Maxim Sokolov, the head of AvtoVAZ.
The impact is felt across the sales chain. Dealer inventories have not been replenished with XRAY units, meaning prospective buyers may no longer find this model in stock. If someone is hoping to purchase a Xray, the option may be fading as the last units have already sold. In practice, the XRAY is becoming harder to obtain, and those who manage to find one may face higher prices.
As for pricing, the current front-wheel-drive hatchback has carried suggested retail prices ranging from 1,106,900 to 1,249,900 rubles. Those figures represent the list price years ago; in reality, the market has not seen XRAY sales at those levels for some time. In many situations, buyers report paying closer to two million rubles for the vehicle due to supply constraints and market dynamics.
The broader takeaway is straightforward: the XRAY is unlikely to re-enter production in the near term, and the supply chain constraints are the dominant factor shaping dealer availability and pricing. The implications extend beyond Russia, hinting at how global component shortages can influence regional auto markets and consumer options for compact crossovers.